Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

A series of analgesic agents prepared and tested by Boehringer Ingelheim

Dec. 15, 2004

New dopamine D3 receptor ligands in early development at Abbott

Dec. 15, 2004

KetoCytonyx completes phase I study of KTX-0101

Dec. 15, 2004

ExonHit synthesizes small molecule in Allergan collaboration

Dec. 15, 2004

Equetro approved for bipolar disorder

Dec. 15, 2004

Helicon launches phase I studies of IPL-455903

Dec. 15, 2004

Enrollment completed in first pivotal study of milnacipran for FMS

Dec. 14, 2004

New adenosine receptor antagonists and their use described in Fujisawa patent

Dec. 14, 2004

New treatments for Parkinson's disease claimed in Schering patent

Dec. 14, 2004

Roche patent covers novel adenosine receptor modulators for Alzheimer's, Parkinson's, etc.

Dec. 14, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...